As we move through 2026, COVID-19 (caused by the SARS-CoV-2 virus) remains a significant part of the global health landscape.
Whilst the acute pandemic phase has ended, the virus continues to evolve, necessitating updated medical guidance and seasonal vaccination programmes.
COVID-19 is an infectious respiratory illness caused by the SARS-CoV-2 coronavirus. First identified in late 2019, the virus has undergone multiple mutations, leading to various “variants of concern.” In 2026, management focuses on the latest dominant strains and their ability to evade prior immunity.
The virus primarily spreads through:
Respiratory Droplets: Small particles expelled during coughing, sneezing, or talking.
Aerosolisation: In poorly ventilated indoor spaces, smaller particles can remain suspended in the air.
Close Contact: Direct physical proximity to an infected individual.
While many cases are now milder due to high population immunity, the core symptoms remain consistent.
Common Symptoms
Respiratory: Persistent cough, shortness of breath, and sore throat.
Systemic: High fever, fatigue, and muscle/joint pains.
Sensory: Loss or change in taste (ageusia) or smell (anosmia).
Gastrointestinal: Diarrhoea and nausea.
5 “Unusual” Symptoms & Complications
“COVID Toes”: Swollen, red, or purple toes (resembling chilblains) seen primarily in younger patients.
Blood Clotting: An increased risk of DVT (Deep Vein Thrombosis) or Pulmonary Embolism due to systemic inflammation.
Neurological Impact: Rarely, patients report “brain fog,” hallucinations, or even psychosis.
Organ Damage: Autoimmune-mediated damage to the heart, kidneys, or liver.
Long COVID: Symptoms persisting beyond 12 weeks, affecting roughly 2% of the UK population.
In 2026, treatment is highly stratified based on the patient’s risk of severe disease.
Mild Cases
Most patients recover at home with rest, hydration, and over-the-counter pain relief (paracetamol).
High-Risk/Severe Cases
For those with underlying health conditions, doctors may prescribe:
Antivirals: Paxlovid (Nirmatrelvir/Ritonavir), Molnupiravir, or Remdesivir to stop the virus from replicating.
Anti-inflammatories: Dexamethasone or Tocilizumab to prevent a “cytokine storm.”
Oxygen Therapy: Essential for patients with low blood oxygen saturation.
Public health strategy has shifted toward protecting the most vulnerable rather than universal boosters. As of the latest update, the NHS offers seasonal vaccinations to:
Adults aged 75 and over.
Residents in care homes for older adults.
Immunosuppressed individuals (aged 6 months and over).
Note: This is a more targeted approach than previous years, focusing on those at the highest risk of hospitalisation.
Based on WHO data updated through late 2025:
Total Global Cases: Over 778 million.
Total Global Deaths: Over 7.1 million.
Case Fatality Rate: Approximately 1% globally, though this is significantly lower in highly vaccinated populations.
Age Risk: Mortality remains highest in the elderly, with rates reaching 15% in those aged 85+.
Despite the shift in policy, standard hygiene remains the best defense:
Hand Hygiene: Regular washing with soap or alcohol-based gel.
Ventilation: Keeping indoor spaces well-ventilated.
Mask-Wearing: Still recommended in high-risk clinical settings or crowded areas for vulnerable individuals.
| Category | Key Information |
| Incubation Period | Typically 5–6 days (range of 2–14 days). |
| Recovery Time | 1–2 weeks for mild; 6+ weeks for severe cases. |
| Long COVID | Symptoms lasting > 3 months; affects ~2% of people. |
| At-Risk Groups | Elderly (75+), Immunosuppressed, and those with CKD or Heart Disease. |
While COVID-19 is no longer a “new” threat, it requires ongoing vigilance. Staying up to date with the latest NHS vaccination eligibility and monitoring for persistent symptoms (Long COVID) are the most effective ways to manage the virus in 2026.
A urinary tract infection (UTI) is one of the most common bacterial infections, particularly in women. UTIs occur when bacteria enter the urinary system and multiply, most often affecting the bladder....
What is Hantavirus – When to Worry and When to See a Doctor What is Hantavirus? Hantaviruses are a family of viruses spread mainly by rodents. While rare, they can cause very serious respiratory...
COVID-19: When to Worry and When to See a Doctor While most cases of COVID-19 are now manageable at home, knowing the difference between a “rough cold” and a medical emergency is vital. Be...
COVID-19 and High Cholesterol: Why you Should Check your Lipids After COVID 1. The COVID-Cholesterol Connection Beyond respiratory issues, 2026 data identifies COVID-19 as a major metabolic disruptor....
